Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience
نویسندگان
چکیده
منابع مشابه
Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experience
INTRODUCTION The role of adjuvant chemotherapy in breast cancer is well established, as are its indications. Likewise, the role of neoadjuvant chemotherapy in locally advanced breast cancer is well established. The use of neoadjuvant chemotherapy in operable breast cancer has only recently become of interest to researchers. PATIENTS AND METHODS This study included 34 cases of operable breast ...
متن کاملNeoadjuvant chemotherapy for operable breast cancer.
Adjuvant systemic chemotherapy has been shown to prolong survival in all subsets of patients with breast cancer. In addition, among patients with locally advanced breast cancer, neoadjuvant orpreoperative chemotherapy has improved the ability to perform breast-conserving therapy. This observation, combined with multiple preclinical hypotheses and the results of laboratory studies, has prompted ...
متن کاملDoes neoadjuvant chemotherapy for breast cancer increase complications during immediate breast reconstruction?
BACKGROUND Neoadjuvant chemotherapy (NAC) has been administered since the 1990s and is now one of the major treatments for breast cancer. It can achieve extremely positive results in some patients. Whether NAC affects immediate breast reconstruction (IBR) using an expander, however, remains unclear. METHODS A retrospective study was performed at Tokyo Medical and Dental University (TMDU) hosp...
متن کاملChanges in Cytokeratin 18 during Neoadjuvant Chemotherapy of Breast Cancer: A Prospective Study
Background & Objective: Premalignant lesions of cervix have increased dramatically in recent years. Early diagnosis and management of abnormalitie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ecancermedicalscience
سال: 2009
ISSN: 1754-6605
DOI: 10.3332/ecancer.2009.104